Technology
Health
Biotechnology

REGENXBIO

601

$39.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.48 (1.22%) Today
$0.00 (0.00%) As of 4:22 PM EDT after-hours

Why Robinhood?

You can buy or sell REGENXBIO and other stocks, options, ETFs, and crypto commission-free!

About RGNX

REGENXBIO Inc. Common Stock, also called REGENXBIO, is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Read More The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

CEO
Kenneth T. Mills
Employees
192
Headquarters
Rockville, Maryland
Founded
2008
Market Cap
1.47B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
716.62K
High Today
$40.20
Low Today
$39.04
Open Price
$39.49
Volume
604.30K
52 Week High
$78.15
52 Week Low
$30.38

Collections

Technology
Health
Biotechnology
Therapy
2015 IPO
US
North America

RGNX Earnings

-$0.89
$0.42
$1.73
$3.04
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 6, After Hours
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy RGNX

Market Price$39.90
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell REGENXBIO stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up